Prolight Diagnostics
0,141
SEK
+3,68 %
PRLD
Nordic SME
Medical Equipment & Services
Health Care
Mindre end 1K følgere
+3,68%
+5,22%
+2,17%
-15,06%
-30,54%
-44,71%
-85,74%
-93,63%
-67,21%
Prolight Diagnostics develops test systems in POCT (Point of care testing). The tests are used outside of hospital laboratories to enable rapid assessments of the health of patients. The company's POCT platform is under development with the intention of measuring various biomarkers simultaneously. An important component of the work is to reduce the time for test results, particularly important for patients with heart problems. The company was founded in 1999 and is based in Lund.
Læs mereMarkedsværdi
98,99 mio. SEK
Aktieomsætning
186,28 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Finanskalender
21.2
2025
Årsrapport '24
14.5
2025
Delårsrapport Q1'25
28.8
2025
Delårsrapport Q2'25
ViserAlle indholdstyper
Prolight strengthens IP portfolio by additional patent application
EMERGERS VALUE PROLIGHT DIAGNOSTICS AT 730 MSEK (0,9- 1,0 SEK PER SHARE)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools